ECTRIMS eLearning

Assessment of perfusion in grey matter cortical lesions in Multiple Sclerosis using high-resolution ASL at 7T
Author(s): ,
R.J Dury
Affiliations:
Sir Peter Mansfield Imaging Centre, University of Nottingham
,
M.G Bright
Affiliations:
Sir Peter Mansfield Imaging Centre, University of Nottingham
,
Y Falah
Affiliations:
Clinical Neurology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
,
P.A Gowland
Affiliations:
Sir Peter Mansfield Imaging Centre, University of Nottingham
,
N Evangelou
Affiliations:
Clinical Neurology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
S.T Francis
Affiliations:
Sir Peter Mansfield Imaging Centre, University of Nottingham
ECTRIMS Learn. Dury R. 09/14/16; 145555; EP1459
Richard J. Dury
Richard J. Dury
Contributions
Abstract

Abstract: EP1459

Type: ePoster

Abstract Category: Pathology and pathogenesis of MS - Imaging

Background: Grey matter (GM) cortical lesions (CL) have been associated with physical disability, cognitive impairment and fatigue in Multiple Sclerosis (MS). One prior study has assessed perfusion in CLs, using dynamic susceptibility contrast (DSC) at 1.5T, and suggested CLs possess reduced cerebral blood flow (CBF) and cerebral blood volume (CBV) compared to normal appearing GM (NAGM). However, recent studies have suggested that the contrast agents used in such techniques accumulates in neuronal tissue and the clinical significance of this is currently unknown.

Goals: This study aims to assess the sensitivity of Arterial Spin Labelling (ASL) to detect the reported CBF reduction in CLs. If proven, this method could provide an alternative to contrast enhanced techniques, particularly in the light of current safety concerns.

Data Acquisition: 7 patients with MS (8 male, 4 female, 48±7.4 years) were scanned on a 7T Philips Achieva system with a 32-channel receive coil. Data were acquired using Flow Alternating Inversion Recovery (FAIR) ASL using a Balanced Fast Field Echo readout to achieve high spatial resolution data (1.2Î1.2Î3 mm3) with good signal-to-noise (SNR) and minimal distortions. Whole-brain Phase Sensitive Inversion Recovery (PSIR) data were collected in order to identify CLs.

Data Analysis: CLs were identified on the PSIR by experienced clinicians and CL binary masks were formed. GM masks were formed using the PSIR data and co-registered to the ASL. The ASL signal was assessed in the CL and within a 12-mm radius of surrounding normal appearing GM.

Results: In total, 15 CLs were identified across 7 MS patients. Four lesions were discarded due to small CL volume (< 16mm3) and two lesions were discarded due to signal contamination from a large vessel. A significant reduction in ASL perfusion signal change of 38±8% was found in CL compared to local GM.

Discussion: Here, we demonstrate a reduced ASL perfusion signal in CLs. In future work we will apply this high spatial resolution ASL technique in a longitudinal study to evaluate perfusion changes in new and chronic CLs, a study for which repeated use of contrast agents would be cautioned against.

Disclosure: Richard J Dury: nothing to declare.

Molly G Bright: nothing to declare.

Yasser Falah: nothing to declare.

Penny A Gowland: nothing to declare.

Nikos Evangelou: nothing to declare.

Susan T Francis: nothing to declare.

Abstract: EP1459

Type: ePoster

Abstract Category: Pathology and pathogenesis of MS - Imaging

Background: Grey matter (GM) cortical lesions (CL) have been associated with physical disability, cognitive impairment and fatigue in Multiple Sclerosis (MS). One prior study has assessed perfusion in CLs, using dynamic susceptibility contrast (DSC) at 1.5T, and suggested CLs possess reduced cerebral blood flow (CBF) and cerebral blood volume (CBV) compared to normal appearing GM (NAGM). However, recent studies have suggested that the contrast agents used in such techniques accumulates in neuronal tissue and the clinical significance of this is currently unknown.

Goals: This study aims to assess the sensitivity of Arterial Spin Labelling (ASL) to detect the reported CBF reduction in CLs. If proven, this method could provide an alternative to contrast enhanced techniques, particularly in the light of current safety concerns.

Data Acquisition: 7 patients with MS (8 male, 4 female, 48±7.4 years) were scanned on a 7T Philips Achieva system with a 32-channel receive coil. Data were acquired using Flow Alternating Inversion Recovery (FAIR) ASL using a Balanced Fast Field Echo readout to achieve high spatial resolution data (1.2Î1.2Î3 mm3) with good signal-to-noise (SNR) and minimal distortions. Whole-brain Phase Sensitive Inversion Recovery (PSIR) data were collected in order to identify CLs.

Data Analysis: CLs were identified on the PSIR by experienced clinicians and CL binary masks were formed. GM masks were formed using the PSIR data and co-registered to the ASL. The ASL signal was assessed in the CL and within a 12-mm radius of surrounding normal appearing GM.

Results: In total, 15 CLs were identified across 7 MS patients. Four lesions were discarded due to small CL volume (< 16mm3) and two lesions were discarded due to signal contamination from a large vessel. A significant reduction in ASL perfusion signal change of 38±8% was found in CL compared to local GM.

Discussion: Here, we demonstrate a reduced ASL perfusion signal in CLs. In future work we will apply this high spatial resolution ASL technique in a longitudinal study to evaluate perfusion changes in new and chronic CLs, a study for which repeated use of contrast agents would be cautioned against.

Disclosure: Richard J Dury: nothing to declare.

Molly G Bright: nothing to declare.

Yasser Falah: nothing to declare.

Penny A Gowland: nothing to declare.

Nikos Evangelou: nothing to declare.

Susan T Francis: nothing to declare.

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies